NPM1 and acute myeloid leukemia: Interestingly, two patients carrying NPM1 mutation and BCR-ABL1 were alive 36 and 71 months after diagnosis [74], suggesting that they may behave more like a NPM1-mutated AML than as de novo AML with BCR-ABL1.